Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New Insights on Properties and Spatial Distributions of Skeletal Stem Cells. | Stem Cells Int | 2019 | 31281389 | PubTator, text mining | PubMed |
| MicroRNA-374a, -4680, and -133b suppress cell proliferation through the regulation of genes associated with human cleft palate in cultured human palate cells. | BMC Med Genomics | 2019 | 31262291 | PubTator, text mining | PubMed |
| Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors. | J Clin Med | 2019 | 31247937 | PubTator, text mining | PubMed |
| Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis. | Cells | 2019 | 31242658 | PubTator, text mining | PubMed |
| Proximity proteomics identifies cancer cell membrane cis-molecular complex as a potential cancer target. | Cancer Sci | 2019 | 31228215 | PubTator, text mining | PubMed |
| Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors. | JCO Precis Oncol | 2019 | 31218271 | PubTator, text mining | PubMed |
| Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma. | Acad Pathol | 2019 | 31206012 | PubTator, text mining | PubMed |
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy). | J Thorac Oncol | 2019 | 31195180 | PubTator, text mining | PubMed |
| FGF Gradient Controls Boundary Position Between Proliferating and Differentiating Cells and Regulates Lacrimal Gland Growth Dynamics. | Front Genet | 2019 | 31191595 | PubTator, text mining | PubMed |
| Stem-cell therapy for hearing loss: are we there yet? | Braz J Otorhinolaryngol | 2019 | 31186186 | PubTator, text mining | PubMed |
| Theoretical prediction of Ni(I)-catalyst for hydrosilylation of pyridine and quinoline. | J Comput Chem | 2019 | 31184780 | PubTator, text mining | PubMed |
| Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy. | Front Endocrinol (Lausanne) | 2019 | 31178825 | PubTator, text mining | PubMed |
| Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations. | Clin Cancer Res | 2019 | 31175097 | PubTator, text mining | PubMed |
| ResMarkerDB: a database of biomarkers of response to antibody therapy in breast and colorectal cancer. | Database (Oxford) | 2019 | 31169290 | PubTator, text mining | PubMed |
| Thioflavin T Monitoring of Guanine Quadruplex Formation in the rs689-Dependent INS Intron 1. | Mol Ther Nucleic Acids | 2019 | 31150930 | PubTator, text mining | PubMed |
| FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer. | J Exp Clin Cancer Res | 2019 | 31142340 | PubTator, text mining | PubMed |
| Prostate Cancer and Bone Metastases: The Underlying Mechanisms. | Int J Mol Sci | 2019 | 31137764 | PubTator, text mining | PubMed |
| Family-Based Next-Generation Sequencing Study Identifies an IL2RG Variant in an Infant with Primary Immunodeficiency. | OMICS | 2019 | 31100039 | PubTator, text mining | PubMed |
| Copy number alterations associated with clinical features in an underrepresented population with breast cancer. | Mol Genet Genomic Med | 2019 | 31099189 | PubTator, text mining | PubMed |
| A Critical E-box in Barhl1 3' Enhancer Is Essential for Auditory Hair Cell Differentiation. | Cells | 2019 | 31096644 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=49